The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis

Journal: Nature

Published: 2020-04-08

DOI: 10.1038/s41586-020-2183-2

Affiliations: 22

Authors: 18

Go to article
Institutions Share
Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, United States of America (USA) 0.13
MOE International Co-operation Laboratory on Signal Transduction, SMMU, China 0.11
Qingdao Cancer Institute at the Affiliated Hospital, QU, China 0.10
Department of Neuro-Oncology, MD Anderson Cancer Center, United States of America (USA) 0.08
Institute of Translational Medicine (ITM), ZJU, China 0.06
Zhejiang Provincial Key Laboratory of Pancreatic Disease at First Affiliated Hospital, ZJU, China 0.06
Department of Biology and Biomedical Science, Dong-A University, South Korea 0.06
Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), UTHealth, United States of America (USA) 0.06
Department of Neurosurgery, Houston Methodist, United States of America (USA) 0.06
Center for Molecular Medicine, CMU, Taiwan 0.03
School of Life Sciences, Tsinghua, China 0.03
MOE Key Laboratory of Laboratory Medicine, WMU, China 0.03
Graduate Institute of Biomedical Sciences, CMU, Taiwan 0.03
School of Laboratory Medicine and Life Science, WMU, China 0.03
CAS Center for Excellence in Biomacromolecules, China 0.03
CAS Key Laboratory of Infection and Immunity, IBP CAS, China 0.03
Department of Cancer Biology, MD Anderson Cancer Center, United States of America (USA) 0.03
School of Public Health (SPH), NJMU, China 0.02
Jiangsu Provincial Key Laboratory of Cancer Biomarkers, Prevention and Treatment, NJMU, China 0.02
Collaborative Innovation Center for Cancer Personalized Medicine, NJMU, China 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER